Machine Learning Model Links Tumor Cell Malignancy to Osteosarcoma Outcomes and Flags OPN3 as a Drug Target Candidate
A machine learning model built from single-cell data stratifies osteosarcoma patients by survival risk and identifies OPN3 as a candidate ...
